Login / Signup

Revisiting the Evidence Base Informing the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis.

Connor ProstyMark SorinKhaled KatergiRoy KhalafClare FogartyMalick TurenneTodd C LeeEmily G McDonald
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Adjunctive therapy with ceftriaxone appeared to be equally effective and less toxic than gentamicin for the treatment of EFIE. The existing evidence does not clearly establish the superiority of either adjunctive therapy or monotherapy. Pending randomized evidence, if adjunctive therapy is to be used, ceftriaxone appears to be a reasonable option.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • stem cells
  • replacement therapy
  • study protocol